A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The second round of negotiations cuts spending an aggregate 44% over 2024 list prices as the federal government extends ...

Medicare beneficiaries will save on top Part D drugs in 2027, with price cuts up to 85% under the Inflation Reduction Act. Read more here.

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...